---
schema_version: "secwatch.filing_event.v1"
accession: "0002001184-26-000009"
form_type: "8-K"
ticker: "PACS"
cik: "0002001184"
company_name: "PACS Group, Inc."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T20:00:25.342534+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PACS Group appoints Optum CEO Dr. Patrick Conway to its Board of Directors

## Summary
- Appointment effective March 4, 2026; Dr. Conway will serve as Class III director until 2027 annual meeting.
- Dr. Conway is CEO of Optum, former CMS Deputy Administrator and CMMI director, and architect of value-based payment models.
- His experience spans clinical practice, federal payment policy, and large-scale health services leadership.
- PACS operates 320+ facilities across 17 states; reported FY2025 revenue of $5.29B (+29.3% YoY).
- Company expects Conway's insight to aid navigation of CMS star ratings, reimbursement models, and regulatory landscape.

## SEC filing metadata
- accession: 0002001184-26-000009
- form_type: 8-K
- ticker: PACS
- cik: 0002001184
- company_name: PACS Group, Inc.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2001184/000200118426000009/0002001184-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2001184/000200118426000009/pacs-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002001184-26-000009
- JSON: https://secwatch.observer/filing/0002001184-26-000009.json
- Plain text: https://secwatch.observer/filing/0002001184-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.